1. Home
  2. EYPT vs OEC Comparison

EYPT vs OEC Comparison

Compare EYPT & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$4.62

Market Cap

419.9M

Sector

Industrials

ML Signal

HOLD

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$6.07

Market Cap

397.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
OEC
Founded
1987
1862
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Major Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
419.9M
397.0M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
EYPT
OEC
Price
$4.62
$6.07
Analyst Decision
Strong Buy
Sell
Analyst Count
5
4
Target Price
$31.80
$6.56
AVG Volume (30 Days)
6.3M
407.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
1.11%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,539,000.00
$1,806,700,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3,115.57
$2.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.95
$4.35
52 Week High
$19.11
$9.30

Technical Indicators

Market Signals
Indicator
EYPT
OEC
Relative Strength Index (RSI) 29.97 43.34
Support Level $3.95 $6.00
Resistance Level $15.17 $6.58
Average True Range (ATR) 0.51 0.31
MACD -0.08 -0.01
Stochastic Oscillator 26.30 25.69

Price Performance

Historical Comparison
EYPT
OEC

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: